GUCY2C
Guanylyl cyclase C
Also known as: GUC2C, GUC2C_HUMAN, STAR
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P25092
- Gene
- GUCY2C
- Ensembl
- ENSG00000070019
- Chromosome
- 12
- Canonical length
- 1073 aa
- Protein class
- Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Vesicles
- Quaternary structure
- Homotrimer
OverviewNCBI Gene
This gene encodes a transmembrane protein that functions as a receptor for endogenous peptides guanylin and uroguanylin, and the heat-stable E. coli enterotoxin. The encoded protein activates the cystic fibrosis transmembrane conductance regulator. Mutations in this gene are associated with familial diarrhea (autosomal dominant) and meconium ileus (autosomal recessive). [provided by RefSeq, Nov 2016]
Canonical amino-acid sequenceUniProt
1073 residues, UniProt reviewed canonical sequence.
>P25092|GUCY2C
1 MKTLLLDLAL WSLLFQPGWL SFSSQVSQNC HNGSYEISVL MMGNSAFAEP LKNLEDAVNE
61 GLEIVRGRLQ NAGLNVTVNA TFMYSDGLIH NSGDCRSSTC EGLDLLRKIS NAQRMGCVLI
121 GPSCTYSTFQ MYLDTELSYP MISAGSFGLS CDYKETLTRL MSPARKLMYF LVNFWKTNDL
181 PFKTYSWSTS YVYKNGTETE DCFWYLNALE ASVSYFSHEL GFKVVLRQDK EFQDILMDHN
241 RKSNVIIMCG GPEFLYKLKG DRAVAEDIVI ILVDLFNDQY FEDNVTAPDY MKNVLVLTLS
301 PGNSLLNSSF SRNLSPTKRD FALAYLNGIL LFGHMLKIFL ENGENITTPK FAHAFRNLTF
361 EGYDGPVTLD DWGDVDSTMV LLYTSVDTKK YKVLLTYDTH VNKTYPVDMS PTFTWKNSKL
421 PNDITGRGPQ ILMIAVFTLT GAVVLLLLVA LLMLRKYRKD YELRQKKWSH IPPENIFPLE
481 TNETNHVSLK IDDDKRRDTI QRLRQCKYDK KRVILKDLKH NDGNFTEKQK IELNKLLQID
541 YYNLTKFYGT VKLDTMIFGV IEYCERGSLR EVLNDTISYP DGTFMDWEFK ISVLYDIAKG
601 MSYLHSSKTE VHGRLKSTNC VVDSRMVVKI TDFGCNSILP PKKDLWTAPE HLRQANISQK
661 GDVYSYGIIA QEIILRKETF YTLSCRDRNE KIFRVENSNG MKPFRPDLFL ETAEEKELEV
721 YLLVKNCWEE DPEKRPDFKK IETTLAKIFG LFHDQKNESY MDTLIRRLQL YSRNLEHLVE
781 ERTQLYKAER DRADRLNFML LPRLVVKSLK EKGFVEPELY EEVTIYFSDI VGFTTICKYS
841 TPMEVVDMLN DIYKSFDHIV DHHDVYKVET IGDAYMVASG LPKRNGNRHA IDIAKMALEI
901 LSFMGTFELE HLPGLPIWIR IGVHSGPCAA GVVGIKMPRY CLFGDTVNTA SRMESTGLPL
961 RIHVSGSTIA ILKRTECQFL YEVRGETYLK GRGNETTYWL TGMKDQKFNL PTPPTVENQQ
1021 RLQAEFSDMI ANSLQKRQAA GIRSQKPRRV ASYKKGTLEY LQLNTTDKES TYFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GUCY2C can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 64 nTPM
Expression across tissuesHPA
Tissue
- duodenum: 64 nTPM
- small intestine: 63 nTPM
- rectum: 39 nTPM
- colon: 35 nTPM
- appendix: 3.2 nTPM
- heart muscle: 2.1 nTPM
Single-cell type
- cardiomyocytes: 473 nCPM
- neuroendocrine cells: 445 nCPM
- enterocytes: 219 nCPM
- paneth cells: 132 nCPM
- goblet cells: 130 nCPM
- colonocytes: 126 nCPM
Immune cell
- memory B-cell: 1.5 nTPM
- naive B-cell: 1.1 nTPM
- neutrophil: 1.1 nTPM
- classical monocyte: 0.6 nTPM
- myeloid DC: 0.3 nTPM
- intermediate monocyte: 0.2 nTPM
Brain region
- choroid plexus: 6.8 nTPM
- spinal cord: 1.6 nTPM
- white matter: 1.5 nTPM
- medulla oblongata: 1.4 nTPM
- basal ganglia: 1 nTPM
- cerebellum: 1 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about GUCY2C.
Disease | AllUniProt
Conditions GUCY2C is implicated in, by any mechanism.
- Diarrhea 6 (DIAR6) MIM:614616
- Meconium ileus (MECIL) MIM:614665
Disease | GeneticClinVar
14 pathogenic / likely-pathogenic of 984 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Congenital diarrhea 6
- Meconium ileus
- Intestinal obstruction in the newborn due to guanylate cyclase 2C deficiency
- Abnormal biliary tract morphology
- Asplenia
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.08
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.25
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cGMP biosynthetic process
- intracellular signal transduction
- receptor guanylyl cyclase signaling pathway
- regulation of cell population proliferation
- response to toxic substance
Molecular functions
- ATP binding
- GTP binding
- guanylate cyclase activity
- peptide receptor activity
- protein kinase activity
- toxic substance binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Protein kinase domain
- Adenylyl cyclase class-3/4/guanylyl cyclase
- Serine-threonine/tyrosine-protein kinase, catalytic domain
- Protein kinase-like domain superfamily
- Adenylyl cyclase class-4/guanylyl cyclase, conserved site
- Periplasmic binding protein-like I
- Nucleotide cyclase
- Cyclic nucleotide synthase
- Adenylate and Guanylate cyclase catalytic domain
- Protein tyrosine and serine/threonine kinase
- Membrane Guanylate Cyclase receptor GC-C, pseudokinase domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GUCY2C in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GUCY2C as an antibody target. Whether an autoantibody or antibody against GUCY2C could matter depends on whether native GUCY2C is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GUCY2C is annotated at the cell surface, where native GUCY2C is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label GUCY2C as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...